BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37827576)

  • 1. Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.
    ; Casco N; Jorge AL; Palmero DJ; Alffenaar JW; Fox GJ; Ezz W; Cho JG; Denholm J; Skrahina A; Solodovnikova V; Arbex MA; Alves T; Rabahi MF; Pereira GR; Sales R; Silva DR; Saffie MM; Salinas NE; Miranda RC; Cisterna C; Concha C; Fernandez I; Villalón C; Vera CG; Tapia PG; Cancino V; Carbonell M; Cruz A; Muñoz E; Muñoz C; Navarro I; Pizarro R; Cristina Sánchez GP; Vergara Riquelme MS; Vilca E; Soto A; Flores X; Garavagno A; Bahamondes MH; Merino LM; Pradenas AM; Revillot ME; Rodriguez P; Salinas AS; Taiba C; Valdés JF; Subiabre JN; Ortega C; Palma S; Castillo PP; Pinto M; Bidegain FR; Venegas M; Yucra E; Li Y; Cruz A; Guelvez B; Victoria Plaza R; Tello Hoyos KY; Cardoso-Landivar J; Van Den Boom M; Andréjak C; Blanc FX; Dourmane S; Froissart A; Izadifar A; Rivière F; Schlemmer F; Manika K; Diallo BD; Hassane-Harouna S; Artiles N; Mejia LA; Gupta N; Ish P; Mishra G; Patel JM; Singla R; Udwadia ZF; Alladio F; Angeli F; Calcagno A; Centis R; Codecasa LR; De Lauretis A; Esposito SMR; Formenti B; Gaviraghi A; Giacomet V; Goletti D; Gualano G; Matteelli A; Migliori GB; Motta I; Palmieri F; Pontali E; Prestileo T; Riccardi N; Saderi L; Saporiti M; Sotgiu G; Spanevello A; Stochino C; Tadolini M; Torre A; Villa S; Visca D; Kurhasani X; Furjani M; Rasheed N; Danila E; Diktanas S; Ridaura RL; Luna López FL; Torrico MM; Rendon A; Akkerman OW; Chizaram O; Al-Abri S; Alyaquobi F; Althohli K; Aguirre S; Teixeira RC; De Egea V; Irala S; Medina A; Sequera G; Sosa N; Vázquez F; Llanos-Tejada FK; Manga S; Villanueva-Villegas R; Araujo D; Sales Marques RD; Socaci A; Barkanova O; Bogorodskaya M; Borisov S; Mariandyshev A; Kaluzhenina A; Vukicevic TA; Stosic M; Beh D; Ng D; Ong CWM; Solovic I; Dheda K; Gina P; Caminero JA; De Souza Galvão ML; Dominguez-Castellano A; García-García JM; Pinargote IM; Fernandez SQ; Sánchez-Montalvá A; Huguet ET; Murguiondo MZ; Bart PA; Mazza-Stalder J; D'Ambrosio L; Kamolwat P; Bakko F; Barnacle J; Bird S; Brown A; Chandran S; Killington K; Man K; Papineni P; Ritchie F; Tiberi S; Utjesanovic N; Zenner D; Hearn JL; Heysell S; Young L
    Eur Respir J; 2023 Nov; 62(5):. PubMed ID: 37827576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival model analysis of tuberculosis treatment among patients with human immunodeficiency virus coinfection.
    Azeez A; Mutambayi R; Odeyemi A; Ndege J
    Int J Mycobacteriol; 2019; 8(3):244-251. PubMed ID: 31512600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of mortality and survival probability distribution among patients on tuberculosis treatment in Vihiga County, Kenya.
    Wekunda PW; Aduda DSO; Guyah B; Odongo J
    Afr Health Sci; 2023 Mar; 23(1):218-230. PubMed ID: 37545936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of HIV-1, HIV-2, and HIV-1+2 dual infection on the outcome of tuberculosis.
    Wejse C; Patsche CB; Kühle A; Bamba FJ; Mendes MS; Lemvik G; Gomes VF; Rudolf F
    Int J Infect Dis; 2015 Mar; 32():128-34. PubMed ID: 25499041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of mortality among drug-resistant tuberculosis patients in Kaduna State, Nigeria.
    Oyefabi AM; Tobin West CI; Ameh S; Jiya EN; Sadiq A; Dauda H; Onoh M
    Niger J Clin Pract; 2023 Jun; 26(6):825-831. PubMed ID: 37470659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insufficient tuberculosis treatment leads to earlier and higher mortality in individuals co-infected with HIV in southern China: a cohort study.
    Zheng Z; Nehl EJ; Zhou C; Li J; Xie Z; Zhou Z; Liang H
    BMC Infect Dis; 2020 Nov; 20(1):873. PubMed ID: 33225919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis treatment survival of HIV positive TB patients on directly observed treatment short-course in Southern Ethiopia: a retrospective cohort study.
    Shaweno D; Worku A
    BMC Res Notes; 2012 Dec; 5():682. PubMed ID: 23234241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment outcome, survival and their risk factors among new tuberculosis patients co-infected with HIV during the Ebola outbreak in Conakry].
    Camara A; Sow MS; Touré A; Diallo OH; Kaba I; Bah B; Diallo TH; Diallo MS; Guilavogui T; Sow OY
    Rev Epidemiol Sante Publique; 2017 Nov; 65(6):419-426. PubMed ID: 29066256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Survival Time to Death Among TB and HIV Co-infected Adult Patients: an Institution-Based Retrospective Cohort Study.
    Lelisho ME; Teshale BM; Tareke SA; Hassen SS; Andargie SA; Merera AM; Awoke S
    J Racial Ethn Health Disparities; 2023 Aug; 10(4):1616-1628. PubMed ID: 35697902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global prevalence, treatment and outcome of tuberculosis and COVID-19 coinfection: a systematic review and meta-analysis (from November 2019 to March 2021).
    Wang Q; Guo S; Wei X; Dong Q; Xu N; Li H; Zhao J; Sun Q
    BMJ Open; 2022 Jun; 12(6):e059396. PubMed ID: 35725250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts.
    Motta I; Centis R; D'Ambrosio L; García-García JM; Goletti D; Gualano G; Lipani F; Palmieri F; Sánchez-Montalvá A; Pontali E; Sotgiu G; Spanevello A; Stochino C; Tabernero E; Tadolini M; van den Boom M; Villa S; Visca D; Migliori GB
    Pulmonology; 2020; 26(4):233-240. PubMed ID: 32411943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of mortality in adults on treatment for human immunodeficiency virus-associated tuberculosis in Botswana: A retrospective cohort study.
    Muyaya LM; Young T; Loveday M
    Medicine (Baltimore); 2018 Apr; 97(16):e0486. PubMed ID: 29668628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycemia during tuberculosis treatment increases morbidity and mortality in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil.
    Moreira J; Castro R; Lamas C; Ribeiro S; Grinsztejn B; Veloso VG
    Int J Infect Dis; 2018 Apr; 69():11-19. PubMed ID: 29253707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and outcomes of COVID-19 admissions in a population with a high prevalence of HIV and tuberculosis: a multicentre cohort study.
    Parker A; Boloko L; Moolla MS; Ebrahim N; Ayele BT; Broadhurst AGB; Mashigo B; Titus G; de Wet T; Boliter N; Rosslee MJ; Papavarnavas N; Abrahams R; Mendelson M; Dlamini S; Taljaard JJ; Prozesky HW; Mowlana A; Viljoen AJ; Schrueder N; Allwood BW; Lalla U; Dave JA; Calligaro G; Levin D; Maughan D; Ntusi NAB; Nyasulu PS; Meintjes G; Koegelenberg CFN; Mnguni AT; Wasserman S
    BMC Infect Dis; 2022 Jun; 22(1):559. PubMed ID: 35725387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.
    Sileshi B; Deyessa N; Girma B; Melese M; Suarez P
    BMC Infect Dis; 2013 Jul; 13():297. PubMed ID: 23815342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of social determinants on tuberculosis/HIV co-infection mortality in southwest Ethiopia: a retrospective cohort study.
    Gesesew H; Tsehaineh B; Massa D; Tesfay A; Kahsay H; Mwanri L
    BMC Res Notes; 2016 Feb; 9():89. PubMed ID: 26868489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.
    Yang CH; Chen KJ; Tsai JJ; Lin YH; Cheng SH; Wang KF; Chiou HY
    BMC Infect Dis; 2014 Jun; 14():304. PubMed ID: 24897928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy.
    Worodria W; Massinga-Loembe M; Mazakpwe D; Luzinda K; Menten J; Van Leth F; Mayanja-Kizza H; Kestens L; Mugerwa RD; Reiss P; Colebunders R;
    J Acquir Immune Defic Syndr; 2011 Sep; 58(1):32-7. PubMed ID: 21654499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors affecting the mortality of HIV-infected patients with pulmonary tuberculosis in the cART era: a retrospective cohort study in China.
    Ji YJ; Liang PP; Shen JY; Sun JJ; Yang JY; Chen J; Qi TK; Wang ZY; Song W; Tang Y; Liu L; Zhang RF; Shen YZ; Lu HZ
    Infect Dis Poverty; 2018 Mar; 7(1):25. PubMed ID: 29587840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of mortality in patients with drug-resistant tuberculosis: A systematic review and meta-analysis.
    Alemu A; Bitew ZW; Worku T; Gamtesa DF; Alebel A
    PLoS One; 2021; 16(6):e0253848. PubMed ID: 34181701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.